Literature DB >> 28334675

Exercise increases serum brain-derived neurotrophic factor in patients with major depressive disorder.

A Kerling1, M Kück2, U Tegtbur2, L Grams2, S Weber-Spickschen2, A Hanke2, B Stubbs3, K G Kahl4.   

Abstract

BACKGROUND: Brain derived neurotrophic factor (BDNF) has been implicated in the pathogenesis of major depressive disorder (MDD). Existing data on exercise treatment in people with MDD are inconsistent concerning the effect of exercise on BDNF pointing either to increased or unaltered BDNF concentrations. However, studies in non-depressed persons demonstrated a significant effect on resting peripheral BDNF concentrations in aerobic training interventions. Given the lack of clarity mentioned above, the current study aimed at examining the effect of adjunctive exercise on serum BDNF levels in guideline based treated patients with MDD.
METHODS: 42 depressed inpatients were included, and randomized either to a 6 week structured and supervised exercise intervention plus treatment as usual (EXERCISE, n=22), or to treatment as usual (TAU, n=20). BDNF serum concentrations were assessed before and after the intervention in both study groups with established immunoassays.
RESULTS: Serum BDNF slightly decreased in the TAU group, whilst there was an increase in BDNF levels in the exercise group. There was a significant time x group effect concerning sBDNF (p=0.030) with repeated ANOVA measures with age and BMI as covariates, suggesting an increase in BDNF concentrations in the EXERCISE group compared to TAU. LIMITATIONS: Though there was no statistic difference in the antidepressant medication between EXERCISE and TAU potential interactions between exercise and medication on the effects of exercise in BDNF cannot be excluded. Gender was not considered as a covariate in ANOVA due to the small number of objects.
CONCLUSIONS: Exercise training given as adjunct to standard guideline based treatment appears to have additional effects on BDNF serum concentrations in people with MDD. Our results add further evidence to the beneficial effects of exercise in the treatment of MDD. Crown
Copyright © 2017. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aerobic exercise; BDNF; Exercise intervention; Major depressive disorder

Mesh:

Substances:

Year:  2017        PMID: 28334675     DOI: 10.1016/j.jad.2017.03.034

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  25 in total

Review 1.  Physical Exercise and Neuroinflammation in Major Depressive Disorder.

Authors:  Zuleide M Ignácio; Renato S da Silva; Marcos E Plissari; João Quevedo; Gislaine Z Réus
Journal:  Mol Neurobiol       Date:  2019-06-21       Impact factor: 5.590

2.  New steps for treating alcohol use disorder: the emerging importance of physical exercise.

Authors:  Mats Hallgren; Davy Vancampfort; Andreas Lundin; Victoria Andersson; Sven Andréasson
Journal:  Psychopharmacology (Berl)       Date:  2018-08-15       Impact factor: 4.530

3.  Higher BDNF plasma levels are associated with a normalization of memory dysfunctions during an antidepressant treatment.

Authors:  Jan Engelmann; Stefanie Wagner; Daniel Wollschläger; Sabine Kaaden; Konrad F Schlicht; Nadine Dreimüller; Dieter F Braus; Marianne B Müller; Oliver Tüscher; Helge Frieling; André Tadić; Klaus Lieb
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-03-30       Impact factor: 5.270

4.  Physical Activity as a Predictor of Clinical Trial Outcomes in Bipolar Depression: A Subanalysis of a Mitochondrial-Enhancing Nutraceutical Randomized Controlled Trial.

Authors:  Melanie M Ashton; Mohammadreza Mohebbi; Alyna Turner; Wolfgang Marx; Michael Berk; Gin S Malhi; Chee H Ng; Sue M Cotton; Seetal Dodd; Jerome Sarris; Malcolm Hopwood; Brendon Stubbs; Olivia M Dean
Journal:  Can J Psychiatry       Date:  2019-11-28       Impact factor: 4.356

Review 5.  The role of exercise in the treatment of depression: biological underpinnings and clinical outcomes.

Authors:  Ryan E Ross; Catherine J VanDerwerker; Michael E Saladin; Chris M Gregory
Journal:  Mol Psychiatry       Date:  2022-10-17       Impact factor: 13.437

6.  Exercise as Medicine for Mental and Substance Use Disorders: A Meta-review of the Benefits for Neuropsychiatric and Cognitive Outcomes.

Authors:  Garcia Ashdown-Franks; Joseph Firth; Rebekah Carney; Andre F Carvalho; Mats Hallgren; Ai Koyanagi; Simon Rosenbaum; Felipe B Schuch; Lee Smith; Marco Solmi; Davy Vancampfort; Brendon Stubbs
Journal:  Sports Med       Date:  2020-01       Impact factor: 11.136

7.  Gallic acid activates hippocampal BDNF-Akt-mTOR signaling in chronic mild stress.

Authors:  Ji-Xiao Zhu; Jia-Ling Shan; Wei-Qiong Hu; Jin-Xiang Zeng; Ji-Cheng Shu
Journal:  Metab Brain Dis       Date:  2018-10-03       Impact factor: 3.584

Review 8.  Effect of Exercise on Major Depressive Disorder and Schizophrenia: A BDNF Focused Approach.

Authors:  Evrim Gökçe; Emel Güneş; Erhan Nalçaci
Journal:  Noro Psikiyatr Ars       Date:  2019-10-15       Impact factor: 1.339

9.  Assessing BDNF as a mediator of the effects of exercise on depression.

Authors:  Kristin L Szuhany; Michael W Otto
Journal:  J Psychiatr Res       Date:  2020-02-08       Impact factor: 4.791

10.  More Reasons to Move: Exercise in the Treatment of Alcohol Use Disorders.

Authors:  Mats Hallgren; Davy Vancampfort; Felipe Schuch; Andreas Lundin; Brendon Stubbs
Journal:  Front Psychiatry       Date:  2017-08-28       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.